Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TCR2 THERAPEUTICS INC. | Chief Business & Strategy | Restricted Stock Unit | 0 | Jun 1, 2023 | Direct | ||
TCR2 THERAPEUTICS INC. | Chief Business & Strategy | Stock Option (Right to Buy) | 0 | $0.74 | Jun 1, 2023 | Direct | |
Trillium Therapeutics Inc. | Title: Senior Vice President, Corporate Development and Strategy | Common Shares | 0 | Nov 17, 2021 | Direct | ||
Trillium Therapeutics Inc. | Title: Senior Vice President, Corporate Development and Strategy | Stock Option (Right to Buy) | 0 | Nov 17, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TCRR | TCR2 THERAPEUTICS INC. | Jun 1, 2023 | 3 | $0 | 4 | Jun 1, 2023 | Chief Business & Strategy |
TCRR | TCR2 THERAPEUTICS INC. | Dec 15, 2022 | 2 | $0 | 4 | Dec 19, 2022 | Chief Business & Strategy |
TCRR | TCR2 THERAPEUTICS INC. | Jan 10, 2022 | 1 | $0 | 4 | Jan 12, 2022 | Chief Business & Strategy |
TCRR | TCR2 THERAPEUTICS INC. | Jan 10, 2022 | 0 | $0 | 3 | Jan 12, 2022 | Chief Business & Strategy |
TRIL | Trillium Therapeutics Inc. | Nov 17, 2021 | 2 | $0 | 4 | Nov 19, 2021 | Title: Senior Vice President, Corporate Development and Strategy |